niceph login

niceph login NEW YORK , Dec. 23, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Chipotle Mexican Grill, Inc. (NYSE: CMG) between February 8, 2024 and October 29, 2024 , both dates inclusive (the "Class Period") and those who purchased Chipotle call options or sold put options during the Class Period, of the important January 10, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Chipotle securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Chipotle class action, go to https://rosenlegal.com/submit-form/?case_id=30587 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 10, 2025 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Chipotle's portion sizes were inconsistent and left many customers dissatisfied with the Company's offerings; (2) in order to address the issue and retain customer loyalty, Chipotle would have to ensure more generous portion sizes, which would increase cost of sales; and (3) as a result, defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Chipotle class action, go to https://rosenlegal.com/submit-form/?case_id=30587 https://rosenlegal.com/submit-form/?case_id=28116 call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm . Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40 th Floor New York , NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/cmg-deadline-cmg-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-chipotle-mexican-grill-inc-securities-fraud-lawsuit-filed-by-the-rosen-law-firm-302338075.html SOURCE THE ROSEN LAW FIRM, P. A.Ola Electric launches limited edition of S1 Pro Sona in real 24-karat pure gold elementsWOBURN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN ), a global leader in AI-powered marketing technology, today announced financial results for its fiscal fourth quarter ended September 30, 2024. "HawkSearch is the leader in AI-powered product discovery. This year we nearly doubled our sales contracts, launched a new HawkSearch site every week, had better than 103% net revenue retention for HawkSearch, and released 5 AI products under the HawkSearch brand,” said Ari Kahn, Bridgeline's President and Chief Executive Officer. "We begin 2025 with the largest sales pipeline in the company's history, an AI product suite that both existing customer and new customers need, and an outstanding industry reputation from customers and analysts.” Financial Highlights - Fourth Quarter of Fiscal Year 2024 Bridgeline Digital, Inc. will hold a conference call today, December 23, 2024, at 4:30 p.m. Eastern Time to discuss these results. The Company's President and Chief Executive Officer, Ari Kahn, and Chief Financial Officer, Thomas Windhausen, will host the call, followed by a question-and-answer period. The details of the conference call and replay are as follows: Bridgeline Digital Fourth Quarter 2024 Earnings Call Monday, December 23, 2024, at 4:30 p.m. ET Once registered, participants will receive dial-in numbers and unique PIN number. Non-GAAP Financial Measures This press release contains the following Non-GAAP financial measures: Adjusted EBITDA, Non-GAAP adjusted net income (loss), and Non-GAAP adjusted net earnings (loss) per diluted share. Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, impairment of goodwill and intangible assets, non-cash warrant related income/expense, changes in fair value of contingent consideration, restructuring and acquisition-related costs, amortization of debt discounts, preferred stock dividends and any related tax effects. Bridgeline uses Adjusted EBITDA and Non-GAAP adjusted net income (loss) as supplemental measures of our performance that are not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). Non-GAAP adjusted net income (loss) and Non-GAAP adjusted net income (loss) per diluted share are calculated as net income (loss) or net income (loss) per share on a diluted basis, excluding, where applicable, amortization of intangible assets, change in fair value of warrants, stock-based compensation, restructuring and acquisition-related costs, goodwill impairment charges, preferred stock dividends and any related tax effects. Bridgeline's management does not consider these Non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these Non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these Non-GAAP financial measures. To compensate for these limitations, Bridgeline management presents Non-GAAP financial measures in connection with GAAP results. Bridgeline urges investors to review the reconciliation of its Non-GAAP financial measures to the comparable GAAP financial measures, which is included in this press release, and not to rely on any single financial measure to evaluate Bridgeline's financial performance. Our definitions of Non-GAAP Adjusted EBITDA and adjusted net income (loss) may differ from and therefore may not be comparable with similarly titled measures used by other companies, thereby limiting their usefulness as comparative measures. As a result of the limitations that Adjusted EBITDA and Non-GAAP adjusted net income (loss) have as an analytical tool, investors should not consider them in isolation, or as a substitute for analysis of our operating results as reported under GAAP. Safe Harbor for Forward-Looking Statements Statement under the Private Securities Litigation Reform Act of 1995 All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, are based on our current expectations, estimates and projections about our industry, management's beliefs, and certain assumptions made by us, all of which are subject to change. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These statements appear in a number of places and include statements regarding the intent, belief or current expectations of Bridgeline Digital, Inc. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions, including, but not limited to, business operations and the business of our customers, suppliers and partners; our ability to retain and upgrade current customers, increasing our recurring revenue, our ability to attract new customers, our revenue growth rate; our history of net loss and our ability to achieve or maintain profitability, instability in the financial markets, including the banking sector; our liability for any unauthorized access to our data or our users' content, including through privacy and data security breaches; any decline in demand for our platform or products; changes in the interoperability of our platform across devices, operating systems, and third party applications that we do not control; competition in our markets; our ability to respond to rapid technological changes, extend our platform, develop new features or products, or gain market acceptance for such new features or products, particularly in light of potential disruptions to the productivity of our employees resulting from remote work; our ability to manage our growth or plan for future growth, and our acquisition of other businesses and the potential of such acquisitions to require significant management attention, disrupt our business, or dilute stockholder value; the volatility of the market price of our common stock, the ability to maintain our listing on the NASDAQ Capital Market; or our ability to maintain an effective system of internal controls as well as other risks described in our filings with the Securities and Exchange Commission. Any of such risks could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement. Bridgeline Digital, Inc. assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release, except as required by applicable law. About Bridgeline Digital Bridgeline is a marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. To learn more, please visit www.bridgeline.com or call (800) 603-9936. Contact: Bridgeline Digital, Inc. Thomas R. Windhausen Chief Financial Officer [email protected]

Should You Buy Snowflake Stock After Its Spectacular Earnings Results?

European stocks bounced around Monday while US equities shook off early weakness to push higher as investors waited to see if a so-called Santa Claus rally sweeps over the market. Global stock markets had a tumultuous time last week, spiraling lower after the US Federal Reserve signaled fewer interest rate cuts than had been expected for 2025. But it ended on a positive note as traders welcomed below-forecast US inflation data that raised hopes about the health of the world's biggest economy. That helped Asian markets move higher on Monday, but the positive trend faltered in Europe and stumbled initially in the United States. "Another up leg in US yields not only put pressure on stock indices but also drove the greenback higher," said IG analyst Axel Rudolph. But after a sluggish start, US stocks rose progressively in a quiet session with analysts pointing to low pre-holiday trading volumes. "Stocks didn't really have any direction in the morning, then we got this tech rally that just sort of drifted higher all day," said Steve Sosnick of Interactive Brokers. Analysts view elevated Treasury bond yields as a threat to year-end gains in an historically strong period of the calendar. Known as a Santa Claus rally, there are various explanations for the phenomenon including seasonal optimism and end-of-year tax considerations. But there remains some trepidation among investors as Donald Trump prepares to return to the White House, pledging to cut taxes, slash regulations and impose tariffs on imports, which some economists warn could reignite inflation. "The initial response to the US election was positive as investors focused on the obvious tailwinds to profitability: lower corporate tax rates and less regulation," said Ronald Temple, chief market strategist at Lazard. "However, I expect much more dispersion within the equity market when the reality of a much-less-friendly trade environment sets in." In Europe, the FTSE 100 moved higher as the pound slid following data that showed that the UK economy stagnated in the third quarter, revised down from initial estimates of 0.1 percent growth. Official data out of Spain on Monday showed that the Spanish economy grew 0.8 percent in the third quarter as domestic consumption and exports increased, comfortably outstripping the European Union average. In company news, shares in crisis-hit German auto giant Volkswagen lost more than three percent on the back of news Friday that it plans to axe 35,000 jobs by 2030 in a drastic cost-cutting plan. Shares in Japanese auto giant Honda rose over three percent after it announced Monday an agreement to launch merger talks with struggling compatriot Nissan that could create the world's third largest automaker. New York - Dow: UP 0.2 percent at 42,906.95 (close) New York - S&P 500: UP 0.7 percent at 5,974.89 (close) New York - Nasdaq Composite: UP 1.0 percent at 19,764.89 (close) London - FTSE 100: UP 0.2 percent at 8,102.72 (close) Paris - CAC 40: FLAT at 7,272.32 (close) Frankfurt - DAX: DOWN 0.2 percent at 19,848.77 (close) Tokyo - Nikkei 225: UP 1.2 percent at 39,161.34 (close) Hong Kong - Hang Seng Index: UP 0.8 percent at 19,883.13 (close) Shanghai - Composite: DOWN 0.5 percent at 3,351.26 (close) Euro/dollar: DOWN at $1.0408 from $1.0430 on Friday Pound/dollar: DOWN at $1.2531 from $1.2570 Dollar/yen: UP at 157.14 yen from 156.31 yen Euro/pound: UP at 83.03 pence from 82.97 pence West Texas Intermediate: DOWN 0.3 percent at $69.24 per barrel Brent North Sea Crude: DOWN 0.4 percent at $72.63 per barrel burs-jmb/jgc

HUNTINGTON, W.V. (AP) — Marshall has withdrawn from the Independence Bowl after a coaching change resulted in much of its roster jumping into the transfer portal. The Thundering Herd were slated to play Army on Dec. 28 in Shreveport, Louisiana. But the Independence Bowl and Louisiana Tech announced on Saturday that the Bulldogs will take on the 19th-ranked Black Knights instead. Marshall said it pulled out “after falling below the roster minimum that was deemed medically safe.” The Herd (10-3) beat Louisiana-Lafayette 31-3 last weekend to win the Sun Belt Conference Championship for the first time. The program has won seven games in a row in the same season for the first time since 2020. “We apologize for the nature and timing of this announcement and for the turmoil it has brought to bowl season preparations for Army, the Radiance Technologies Independence Bowl, the American Athletic Conference and ESPN,” Sun Belt Commissioner Keith Gill said in a statement. Coach Charles Huff left Marshall for Southern Miss last Sunday, and Tony Gibson, the defensive coordinator at North Carolina State, was announced as his replacement less than an hour later. By Thursday, at least 25 Marshall players had entered the transfer portal. Gibson held a meeting shortly after arriving on campus in Huntington to introduce himself to the team. He followed that up with phone calls, text messages and more meetings Friday and Saturday. “Any time coaches leave to take other jobs, it is emotional,” Gibson said at a news conference Thursday. “And kids that are 18-to-22 years old are going to make emotional decisions instead of just breathing for a day or two.” It's the first bowl for Louisiana Tech (5-7) since 2020. The Bulldogs have won two of their last three games, but they haven't played since a 33-0 victory over Kennesaw State on Nov. 30. “We are excited to accept the opportunity to play in the Radiance Technologies Independence Bowl against a fantastic and storied program as Army,” Louisiana Tech athletic director Ryan Ivey said in a release. “I believe our football program is moving toward positive structure and the opportunity to play in this bowl adds to that momentum. We are looking forward to being in Shreveport for this matchup.” Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballRECELL GO mini AVITA Medical receives FDA approval of RECELL GO mini, a new addition to the RECELL Spray-On SkinTM technology platform. RECELL GO mini addresses a critical need in the full-thickness skin defect market, which includes a high volume of smaller wounds. As part of the RECELL GO platform, RECELL GO mini uses the same multi-use processing device as the standard disposable cartridge but features a modified cartridge optimized for smaller skin samples that reduces resource use and minimizes waste. This design provides an entry point for clinicians who may not have previously used the RECELL GO platform for smaller wounds, enabling broader accessibility and use in trauma and burn centers. "The FDA approval of RECELL GO mini strengthens our ability to provide clinicians with fit-for-purpose solutions that meet the diverse needs of patients with full-thickness wounds,” said Jim Corbett, Chief Executive Officer of AVITA Medical. "By introducing a treatment option specifically for smaller wounds, we are expanding the accessibility of RECELL to a wider range of patients. We believe this addition will drive greater adoption across trauma centers, where smaller wounds are common, and support our broader growth strategy.” The company expects RECELL GO mini to serve as a growth driver within the broader RECELL GO platform, further advancing AVITA Medical's strategy to expand its impact on patient care. Rollout will begin with trauma and burn centers that currently treat smaller wounds during the first quarter of 2025. The PMA supplement follows the original PMA of RECELL Autologous Cell Harvesting Device and subsequent PMA supplements. About AVITA Medical, Inc. AVITA Medical is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin restoration with innovative devices. At the forefront of our platform is the RECELL System, approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient's own skin to create Spray-On Skin TM Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. In the United States, AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm ® , a biosynthetic wound matrix, and Cohealyx, an AVITA Medical-branded collagen-based dermal matrix. In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns, full-thickness skin defects, and vitiligo. The RECELL System, excluding RECELL GO TM , is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan. To learn more, visit www.avitamedical.com . Forward-Looking Statements Th is press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements generally may be identified by the use of words such as "anticipate,” "expect,” "intend,” "could,” "would,” "may,” "will,” "believe,” "continue,” "estimate,” "look forward,” "forecast,” "goal,” "target,” "project,” "outlook,” "guidance,” "future,” and similar words or expressions, and the use of future dates. Forward-looking statements include, but are not limited to, statements relating to the timing and realization of regulatory approvals of our products; physician acceptance, endorsement, and use of our products; anticipated market share growth and revenue generation from certain products; failure to achieve the anticipated benefits from approval of our products; the effect of regulatory actions; product liability claims; risks associated with international operations and expansion; and other business effects, including the effects of industry, as well as other economic or political conditions outside of the Company's control. These statements are made as of the date of this release, and the Company undertakes no obligation to publicly update or revise any of these statements, except as required by law. For additional information and other important factors that may cause actual results to differ materially from forward-looking statements, please see the "Risk Factors” section of the Company's latest Annual Report on Form 10-K and other publicly available filings for a discussion of these and other risks and uncertainties. Authorized for release by the Chief Financial Officer of AVITA Medical, Inc. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b6b7df71-e67c-4a6e-847c-bdcca54fad27 CONTACT: Investor & Media Contact: Jessica Ekeberg Phone +1-661-904-9269 [email protected] [email protected]

Report: Iowa CB Jermari Harris opts out of rest of season

As the festive season unfolds, with its customary indulgence in Christmas cheer and New Year's celebrations, many will partake in a merry glass or two. However, we've all felt the grim aftermath of one too many drinks , characterised by headaches , nausea, dehydration, and fatigue . Yet, there's comfort in knowing that proactive steps can be taken to ameliorate the unwanted health effects associated with holiday boozing. Enter Dr Francesca Jackson-Spence who, in her piece for the Sunday Telegraph, offers up some sage advice. 1. Ensure you keep water with you Firstly, keeping water close at hand is crucial. Dr Jackson-Spence states: "During the summer months, we get into the habit of carrying water with us." She highlights the importance of hydration on non-drinking days or even days following alcohol consumption to counterbalance alcohol's diuretic effects and prevent dehydration and subsequent headaches. She notes that fluid requirements can vary depending on individual factors such as weight, height, and activity levels, but generally advises a daily intake of about two litres. She points out that your urine should ideally be "light straw colour", reports Gloucestershire Live . 2. Have some alcohol-free days Furthermore, embracing alcohol-free days during the holidays is another tip offered by Dr Jackson-Spence to maintain good health amidst the festive revelry. She emphasised the importance of moderation when it comes to alcohol consumption. Despite the weekly limit being 21 units, she warns that we risk exceeding this during the festive season. She recommends having at least two alcohol-free days each week to allow the liver's cells to regenerate and address any inflammation caused by drinking. 3. Keep an eye on your diet Keeping an eye on your diet is also crucial. As many are aware, alcohol can affect our decision-making, including our food choices. Often, we might opt for a takeaway or easy meal. Dr Jackson-Spence advises against this, as these meals are typically high in sugar and salt. Instead, she suggests stocking up on whole and plant-based foods. 4. Be more selective with drinks Being selective with your drinks is another tip from Dr Jackson-Spence. While alcohol naturally increases our need to use the toilet, the mixers we choose can also affect our hydration levels. She advises pacing yourself and opting for non-alcoholic mixers, which could help limit your overall alcohol intake. 5. Stop in the new year Lastly, Dr Jackson-Spence encourages setting a date to stop the festive drinking, allowing you to return to your regular routine in the new year. The NHS advises that both men and women should not regularly drink more than 14 units of alcohol per week. A single unit of alcohol is equivalent to 8g or 10ml of pure alcohol. This is roughly the same as half a pint of lager, beer or cider with an ABV of 3.6%, or one 25ml shot of spirits with an ABV of 40%. Alternatively, a small 125ml glass of wine with an ABV of 12% contains approximately 1.5 units. If you'd like to learn more about alcohol misuse, visit the NHS website here .ARLINGTON, Texas (AP) — Lance Ware had 17 points in UT Arlington's 77-68 win over UL Monroe on Saturday. Ware had six rebounds and three blocks for the Mavericks (5-6). Diante Smith shot 5 of 11 from the field, including 2 for 7 from 3-point range, and went 4 for 4 from the line to add 16 points. Brody Robinson shot 2 for 5 (1 for 4 from 3-point range) and 6 of 8 from the free-throw line to finish with 11 points. Makai Willis led the Warhawks (4-8) in scoring, finishing with 18 points, 13 rebounds and two blocks. Tyreese Watson added 15 points, six rebounds and four assists for UL Monroe. Jalen Bolden also had 13 points, 15 rebounds, seven assists and three steals. UT Arlington next plays Wednesday against Evansville at home, and UL Monroe will host Houston Christian on Tuesday. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

Shohei Ohtani wins 3rd AP Male Athlete of the Year award, tying Michael Jordan for 1 shy of record

PL Predictions: Forest to turn up heat on stubborn Ange

Three semiconductor units to be set up in NE will create 80K jobs: HM Shah